Cyprus Mail
CyprusPodcast

Daily News Briefing

nov 17 23

In today’s episode, health authorities in the United Kingdom have approved a drug which aims to cure beta thalassaemia and sickle cell disease.

The drug is called Casgevy and utilises a gene-editing tool as Crispr to manipulate the DNA of beta thalassaemia and sickle cell disease sufferers.

Meanwhile, Parliament passed a new law on Thursday which sets out the rights and responsibilities of both employees who work remotely and their employers.

Elsewhere, the forestry department in a written report has blamed the electricity authority (EAC) for the near catastrophic fires in Paphos forest, as well as that in Palaichori, this past summer.

All this and more in the Cyprus Beat briefing brought to you by the Cyprus Mail.

Follow the Cyprus Mail on Google News

Related Posts

Paphos village’s green award ‘an honour’

Tom Cleaver

Limassol theatre celebrates 25 years with special concert

Eleni Philippou

Von der Leyen to visit Cyprus on EU accession anniversary

Tom Cleaver

EU accession ‘the culmination of a titanic effort’

Tom Cleaver

‘Cyprus is a reliable business centre’

Tom Cleaver

Rising Italian star shakes up Nicosia food scene

Jonathan Shkurko